Kubens B S, Krumbacher K, Grosse-Wilde H
Department of Immunology, University Hospital of Essen, Medical School, Germany.
Eur J Immunogenet. 1995 Apr;22(2):199-207. doi: 10.1111/j.1744-313x.1995.tb00231.x.
The serologically defined canine MHC gene products (DLA-A and DLA-B) were investigated by one-dimensional isoelectric focusing after detergent phase separation, and immunoblotting (1D-IEF). The animals studied (n = 36) represented three different breeds. Since DLA-A and DLA-B antigens are MHC class I and class II molecules, respectively, cross-reactive polyclonal antibodies specific for human class I or class II molecules were utilized to visualize the protein pattern. The relative positions of the bands were correlated with the DLA-A and DLA-B antigens. In most cases DLA antigens of identical serological type did not differ in their 1D-IEF pattern except for DLA-A9 and the serologically undefined DLA-B gene product DLA-B 'blank'. For DLA-A9, two subtypes (A9.1 and A9.2) were identified in Beagle and associations of A9.1 with the haplotype A9,B4 and of A9.2 with A9,B6 were seen. In contrast, the haplotype A9,B6 in Labradors was associated with A9.1. Whereas all six serologically defined DLA-A antigens possessed distinct isoelectric points (IEP), not all DLA-B antigens could be differentiated by 1D-IEF:B5 as well as B13 coband with one B 'blank' specificity (BE1). Furthermore, a second B 'blank' (BE2) could be identified by 1D-IEF, underlining the advantage of this technique in the immunogenetic analysis of DLA gene products in dogs.
通过去污剂相分离后的一维等电聚焦和免疫印迹法(1D-IEF),对血清学定义的犬MHC基因产物(DLA-A和DLA-B)进行了研究。所研究的动物(n = 36)代表三个不同品种。由于DLA-A和DLA-B抗原分别是MHC I类和II类分子,因此使用对人类I类或II类分子具有交叉反应性的多克隆抗体来观察蛋白质图谱。条带的相对位置与DLA-A和DLA-B抗原相关。在大多数情况下,除了DLA-A9和血清学未定义的DLA-B基因产物DLA-B“空白”外,相同血清学类型的DLA抗原在其1D-IEF图谱中没有差异。对于DLA-A9,在比格犬中鉴定出两个亚型(A9.1和A9.2);观察到A9.1与单倍型A9,B4相关,A9.2与A9,B6相关。相比之下,拉布拉多犬中的单倍型A9,B6与A9.1相关。虽然所有六种血清学定义的DLA-A抗原都具有不同的等电点(IEP),但并非所有DLA-B抗原都能通过1D-IEF区分:B5以及B13与一种B “空白”特异性(BE1)共带。此外,通过1D-IEF可以鉴定出第二种B “空白”(BE2),突出了该技术在犬DLA基因产物免疫遗传学分析中的优势。